Ardelyx Stock Z Score

ARDX Stock  USD 7.30  0.11  1.48%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Ardelyx Piotroski F Score and Ardelyx Valuation analysis.
For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.
  
Capital Lease Obligations is likely to rise to about 8 M in 2024, whereas Capital Surpluse is likely to drop slightly above 568.4 M in 2024. At this time, Ardelyx's Reconciled Depreciation is fairly stable compared to the past year.

Ardelyx Z Score Analysis

Ardelyx's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2021 2022 2023 2024 (projected)
Other Current Liabilities12.8M19.9M27.6M29.0M
Total Assets149.9M190.1M297.6M180.1M

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

Current Ardelyx Z Score

    
  15.07  
Most of Ardelyx's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ardelyx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Ardelyx Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Ardelyx is extremely important. It helps to project a fair market value of Ardelyx Stock properly, considering its historical fundamentals such as Z Score. Since Ardelyx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ardelyx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ardelyx's interrelated accounts and indicators.
0.720.93-0.53-0.580.05-0.740.510.480.40.480.870.540.990.240.680.840.560.670.660.49-0.470.60.45-0.43
0.720.62-0.26-0.270.45-0.860.390.840.720.480.770.730.660.070.310.790.580.920.420.06-0.850.820.71-0.79
0.930.62-0.72-0.76-0.16-0.540.490.270.380.40.720.260.950.380.860.650.470.460.550.44-0.30.350.22-0.22
-0.53-0.26-0.720.960.170.29-0.430.12-0.1-0.49-0.450.12-0.59-0.63-0.76-0.37-0.45-0.13-0.19-0.160.040.060.0-0.01
-0.58-0.27-0.760.960.130.27-0.50.1-0.22-0.47-0.450.11-0.64-0.62-0.76-0.36-0.37-0.13-0.25-0.250.060.050.01-0.04
0.050.45-0.160.170.13-0.480.20.610.530.260.250.65-0.03-0.18-0.410.310.090.560.13-0.13-0.720.510.53-0.58
-0.74-0.86-0.540.290.27-0.48-0.44-0.77-0.44-0.71-0.93-0.84-0.68-0.17-0.21-0.95-0.8-0.95-0.41-0.040.79-0.88-0.850.86
0.510.390.49-0.43-0.50.2-0.440.340.410.240.510.240.480.250.30.480.340.380.10.02-0.220.30.24-0.25
0.480.840.270.120.10.61-0.770.340.770.220.580.840.38-0.3-0.090.630.40.920.33-0.05-0.870.890.72-0.83
0.40.720.38-0.1-0.220.53-0.440.410.770.060.310.490.33-0.130.080.310.070.640.30.03-0.740.530.39-0.52
0.480.480.4-0.49-0.470.26-0.710.240.220.060.730.360.450.670.140.720.830.530.03-0.17-0.420.50.73-0.63
0.870.770.72-0.45-0.450.25-0.930.510.580.310.730.640.820.320.430.990.840.810.420.18-0.550.80.76-0.7
0.540.730.260.120.110.65-0.840.240.840.490.360.640.48-0.27-0.090.70.40.890.570.19-0.870.810.69-0.76
0.990.660.95-0.59-0.64-0.03-0.680.480.380.330.450.820.480.270.750.780.520.590.680.53-0.410.490.34-0.32
0.240.070.38-0.63-0.62-0.18-0.170.25-0.3-0.130.670.32-0.270.270.390.260.55-0.01-0.3-0.30.14-0.080.24-0.15
0.680.310.86-0.76-0.76-0.41-0.210.3-0.090.080.140.43-0.090.750.390.350.290.10.410.430.06-0.05-0.160.15
0.840.790.65-0.37-0.360.31-0.950.480.630.310.720.990.70.780.260.350.830.850.430.16-0.590.850.8-0.75
0.560.580.47-0.45-0.370.09-0.80.340.40.070.830.840.40.520.550.290.830.66-0.03-0.29-0.370.640.78-0.72
0.670.920.46-0.13-0.130.56-0.950.380.920.640.530.810.890.59-0.010.10.850.660.410.0-0.90.930.84-0.91
0.660.420.55-0.19-0.250.13-0.410.10.330.30.030.420.570.68-0.30.410.43-0.030.410.89-0.430.330.05-0.09
0.490.060.44-0.16-0.25-0.13-0.040.02-0.050.03-0.170.180.190.53-0.30.430.16-0.290.00.89-0.010.0-0.280.31
-0.47-0.85-0.30.040.06-0.720.79-0.22-0.87-0.74-0.42-0.55-0.87-0.410.140.06-0.59-0.37-0.9-0.43-0.01-0.75-0.680.79
0.60.820.350.060.050.51-0.880.30.890.530.50.80.810.49-0.08-0.050.850.640.930.330.0-0.750.91-0.91
0.450.710.220.00.010.53-0.850.240.720.390.730.760.690.340.24-0.160.80.780.840.05-0.28-0.680.91-0.97
-0.43-0.79-0.22-0.01-0.04-0.580.86-0.25-0.83-0.52-0.63-0.7-0.76-0.32-0.150.15-0.75-0.72-0.91-0.090.310.79-0.91-0.97
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

In accordance with the company's disclosures, Ardelyx has a Z Score of 15.07. This is 123.26% higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The z score for all United States stocks is 72.82% lower than that of the firm.

Ardelyx Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ardelyx's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ardelyx could also be used in its relative valuation, which is a method of valuing Ardelyx by comparing valuation metrics of similar companies.
Ardelyx is currently under evaluation in z score category among related companies.

Ardelyx Institutional Holders

Institutional Holdings refers to the ownership stake in Ardelyx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ardelyx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ardelyx's value.
Shares
T. Rowe Price Associates, Inc.2023-12-31
2.3 M
Goldman Sachs Group Inc2023-12-31
2.2 M
Northern Trust Corp2023-12-31
2.2 M
Barclays Plc2023-12-31
2.2 M
Nuveen Asset Management, Llc2023-12-31
2.1 M
Charles Schwab Investment Management Inc2023-12-31
1.8 M
J. Goldman & Co Lp2023-12-31
1.6 M
Rafferty Asset Management, Llc2023-12-31
1.4 M
Lion Point Capital, Lp2023-12-31
1.2 M
Hhg Plc2023-12-31
24.7 M
State Street Corporation2023-12-31
17.1 M

Ardelyx Fundamentals

About Ardelyx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ardelyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ardelyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ardelyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Ardelyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 86 people.

Pair Trading with Ardelyx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ardelyx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ardelyx Stock

  0.77CLVRW Clever Leaves HoldingsPairCorr

Moving against Ardelyx Stock

  0.57VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.49MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
  0.47DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.45MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.43VAXX Vaxxinity Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Ardelyx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ardelyx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ardelyx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ardelyx to buy it.
The correlation of Ardelyx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ardelyx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ardelyx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ardelyx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ardelyx offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ardelyx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ardelyx Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ardelyx Stock:
Check out Ardelyx Piotroski F Score and Ardelyx Valuation analysis.
For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.
Note that the Ardelyx information on this page should be used as a complementary analysis to other Ardelyx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Ardelyx Stock analysis

When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Directory
Find actively traded commodities issued by global exchanges
Is Ardelyx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ardelyx. If investors know Ardelyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ardelyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.30)
Revenue Per Share
0.567
Quarterly Revenue Growth
(0.22)
Return On Assets
(0.16)
Return On Equity
(0.50)
The market value of Ardelyx is measured differently than its book value, which is the value of Ardelyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ardelyx's value that differs from its market value or its book value, called intrinsic value, which is Ardelyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ardelyx's market value can be influenced by many factors that don't directly affect Ardelyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ardelyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ardelyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ardelyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.